|
1
|
Fiorentini G AC, Montagnani F, Tilli M,
Mambrini A and Benea G: Trans-arterial chemoembolisation of
metastatic colorectal carcinoma (mCRC) to the liver adopting
polyvinylalcohol microspheres loaded with irinotecan (DEBIRI)
compared to FOLFIRI (CT): evaluation at two years of a phase III
clinical trial. Ann Oncol. 21:2010.
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pazdur R, Coia L, Hoskins WJ and Wagman
LD: Cancer management: a multidisciplinary approach. Medical,
Surgical and Radiation Oncology. 7th edition. CMP Healthcare Media;
New York, NY: 2004
|
|
4
|
Fong Y, Cohen AM, Fortner JG, et al: Liver
resection for colorectal metastases. J Clin Oncol. 15:938–946.
1997.PubMed/NCBI
|
|
5
|
Adam R: Chemotherapy and surgery: new
perspectives on the treatment of unresectable liver metastases. Ann
Oncol. 14(Suppl 2): ii13–ii16. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Adam R, Delvart V, Pascal G, et al: Rescue
surgery for unresectable colorectal liver metastases downstaged by
chemotherapy: a model to predict long-term survival. Ann Surg.
240:644–658. 2004.PubMed/NCBI
|
|
7
|
Stangl R, Altendorf-Hofmann A, Charnley RM
and Scheele J: Factors influencing the natural history of
colorectal liver metastases. Lancet. 343:1405–1410. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Scheele J, Stang R, Altendorf-Hofmann A
and Paul M: Resection of colorectal liver metastases. World J Surg.
19:59–71. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fong Y: Hepatic colorectal metastasis:
current surgical therapy, selection criteria for hepatectomy, and
role for adjuvant therapy. Adv Surg. 34:351–381. 2000.PubMed/NCBI
|
|
10
|
Fong Y and Blumgart LH: Hepatic colorectal
metastasis: current status of surgical therapy. Oncology (Williston
Park). 12:1489–1503. 1998.PubMed/NCBI
|
|
11
|
Meyerhardt JA and Mayer RJ: Systemic
therapy for colorectal cancer. N Engl J Med. 352:476–487. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kennedy A, Nag S, Salem R, et al:
Recommendations for radioembolization of hepatic malignancies using
yttrium-90 microsphere brachytherapy: a consensus panel report from
the radioembolization brachytherapy oncology consortium. Int J
Radiat Oncol Biol Phys. 68:13–23. 2007. View Article : Google Scholar
|
|
13
|
Germer CT, Buhr HJ and Isbert C:
Nonoperative ablation for liver metastases. Possibilities and
limitations as a curative treatment. Chirurg. 76:552–563. 2005.(In
German).
|
|
14
|
Brown DB, Geschwind JF, Soulen MC,
Millward SF and Sacks D: Society of Interventional Radiology
position statement on chemoembolization of hepatic malignancies. J
Vasc Interv Radiol. 17:217–223. 2006. View Article : Google Scholar
|
|
15
|
Bavisotto LM, Patel NH, Althaus SJ, et al:
Hepatic transcatheter arterial chemoembolization alternating with
systemic protracted continuous infusion 5-fluorouracil for
gastrointestinal malignancies metastatic to liver: a phase II trial
of the Puget Sound Oncology Consortium (PSOC 1104). Clin Cancer
Res. 5:95–109. 1999.
|
|
16
|
Vogl TJ, Straub R, Eichler K, Sollner O
and Mack MG: Colorectal carcinoma metastases in liver:
laser-induced interstitial thermotherapy - local tumor control rate
and survival data. Radiology. 230:450–458. 2004. View Article : Google Scholar
|
|
17
|
Fiorentini G, Aliberti C, Turrisi G, et
al: Intraarterial hepatic chemoembolization of liver metastases
from colorectal cancer adopting irinotecan-eluting beads: results
of a phase II clinical study. In Vivo. 21:1085–1091. 2007.
|
|
18
|
Aliberti C, Tilli M, Benea G and
Fiorentini G: Trans-arterial chemoembolization (TACE) of liver
metastases from colorectal cancer using irinotecan-eluting beads:
preliminary results. Anticancer Res. 26:3793–3795. 2006.
|
|
19
|
Rofe APS: A preclinical study to evaluate
the plasma levels of irinotecan after hepatic embolisation using
drug loaded in a porcine model. Institute of Medical and Veterinary
Science; Adelaide: 2006
|
|
20
|
Therasse P, Arbuck SG, Eisenhauer EA, et
al: New guidelines to evaluate the response to treatment in solid
tumors European Organization for Research and Treatment of Cancer,
National Cancer Institute of the United States, National Cancer
Institute of Canada. J Natl Cancer Inst. 92:205–216. 2000.
View Article : Google Scholar
|
|
21
|
Locker GY, Hamilton S, Harris J, et al:
ASCO 2006 update of recommendations for the use of tumor markers in
gastrointestinal cancer. J Clin Oncol. 24:5313–5327. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chong G and Cunningham D: Improving
long-term outcomes for patients with liver metastases from
colorectal cancer. J Clin Oncol. 23:9063–9066. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cohen AD and Kemeny NE: An update on
hepatic arterial infusion chemotherapy for colorectal cancer.
Oncologist. 8:553–566. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Saltz LB, Cox JV, Blanke C, et al:
Irinotecan plus fluorouracil and leucovorin for metastatic
colorectal cancer. Irinotecan Study Group N Engl J Med.
343:905–914. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Leonard GD, Brenner B and Kemeny NE:
Neoadjuvant chemotherapy before liver resection for patients with
unresectable liver metastases from colorectal carcinoma. J Clin
Oncol. 23:2038–2048. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Llovet JM and Beaugrand M: Hepatocellular
carcinoma: present status and future prospects. J Hepatol. 38(Suppl
1): S136–S149. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lo CM, Ngan H, Tso WK, et al: Randomized
controlled trial of transarterial lipiodol chemoembolization for
unresectable hepatocellular carcinoma. Hepatology. 35:1164–1171.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Llovet JM and Bruix J: Systematic review
of randomized trials for unresectable hepatocellular carcinoma:
chemoembolization improves survival. Hepatology. 37:429–442. 2003.
View Article : Google Scholar
|
|
29
|
Barber FD, Mavligit G and Kurzrock R:
Hepatic arterial infusion chemotherapy for metastatic colorectal
cancer: a concise overview. Cancer Treat Rev. 30:425–436. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wallace S, Carrasco CH, Charnsangavej C,
Richli WR, Wright K and Gianturco C: Hepatic artery infusion and
chemoembolization in the management of liver metastases. Cardiovasc
Intervent Radiol. 13:153–160. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vogl TJ, Gruber T, Balzer JO, Eichler K,
Hammerstingl R and Zangos S: Repeated transarterial
chemoembolization in the treatment of liver metastases of
colorectal cancer: prospective study. Radiology. 250:281–289. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Martin RC, Robbins K, Tomalty D, et al:
Transarterial chemoembolisation (TACE) using irinotecan-loaded
beads for the treatment of unresectable metastases to the liver in
patients with colorectal cancer: an interim report. World J Surg
Oncol. 7:802009. View Article : Google Scholar
|
|
33
|
Pfizer: Camptosar® - irinotecan
hydrochloride injection. Prescribing information (US), 2008.
|
|
34
|
de Forni M, Bugat R, Chabot GG, et al:
Phase I and pharmacokinetic study of the camptothecin derivative
irinotecan, administered on a weekly schedule in cancer patients.
Cancer Res. 54:4347–4354. 1994.PubMed/NCBI
|
|
35
|
Pazdur R: Irinotecan: toward clinical end
points in drug development. Oncology (Williston Park). 12:13–21.
1998.
|
|
36
|
Lencioni R, Malagari K, Vogl T, et al: A
randomized phase II trial of a drug eluting bead in the treatment
of hepatocellular carcinoma by transcatheter arterial
chemoembolization. In: Proc ASCO Annual Meeting. ASCO GI;
Alexandria, VA. 2009
|
